Table 5.
Distribution of serum 25(OH)D concentrations greater than 20 ng/mL, 50 ng/mL and 100 ng/mL at baseline and post-treatment in each phototherapy clinical trial.
| Baseline | Baseline | Post-Tx | Post-Tx | Post-Tx | |||
|---|---|---|---|---|---|---|---|
| Study | 25(OH)D | 25(OH)D | 25(OH)D | 25(OH)D | 25(OH)D | ||
| Year | Group | N | N > 20 ng/mL | N > 50 ng/mL | N > 20 ng/mL | N > 50 ng/mL | N > 100 ng/mL |
| 1996 | UVB + Placebo | 7 | 7 | 2 | 7 | 6 | 2 |
| UVB + Calcitirol | 6 | 4 | 0 | 6 | 4 | 1 | |
| 2010 | UVB | 29 | 19 | 0 | 29 | 15 | 1+ |
| No UVB | 29 | NR | 0 | 7 | 0 | 0 | |
| 2009 | BB-UVB | 26 | 65 | 5 | 68 | 48 | 3 |
| NB-UVB | 42 | ||||||
| 2010 | BB-UVB | 24 | 22 | 3 | 24 | 17 | 0 |
| Sunshine | 20 | 17 | 0 | 20 | 4 | 0 | |
| Total | 183 | 134 | 10 | 161 | 94 | 6 |
Note: N = number of patients.